María de Lourdes Mora-García

5PUBLICATIONS
23CO-AUTHORS
Dental therapeutics, pharmacology and toxicologySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 14, 2024
Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Luis Ignacio Poblano-Pérez, Alberto Monroy-García, Gladis Fragoso-González

|Apr 13, 2024
Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF-β1.

Luis Antonio Marín-Aquino, María de Lourdes Mora-García, Martha C Moreno-Lafont

|Feb 27, 2023
Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin.

Monserrat Carrera-Martínez, María de L Mora-García, Rosario García-Rocha

|Sep 07, 2022
Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-β production.

Rosario García-Rocha, Alberto Monroy-García, Monserrat Carrera-Martínez

|Jan 25, 2021
Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.

Ricardo Muñóz-Godínez, María de Lourdes Mora-García, Benny Weiss-Steider

Pageof 1

Frequent Collaborators

5 joint publications

Juan José Montesinos-Montesinos

5 joint publications

Alberto Monroy-García

4 joint publications

Rosario García-Rocha

4 joint publications

Benny Weiss-Steider